The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP

Files
Douros2025Agony-CCBY.pdf (2.61 MB)
Date
2025-02-03
Authors
Douros, Jonathan D.
Flak, Jonathan N.
Knerr, Patrick J.
Language
American English
Embargo Lift Date
Department
Pharmacology and Toxicology, School of Medicine
Committee Members
Degree
Degree Year
Department
Grantor
Journal Title
Journal ISSN
Volume Title
Found At
Frontiers Media
Abstract
Description
Keywords
GIP - glucose-dependent insulinotropic peptide, GLP-1 - glucagon-like peptide-1, Incretin, Obesity, Pharmacology
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Douros JD, Flak JN, Knerr PJ. The agony and the efficacy: central mechanisms of GLP-1 induced adverse events and their mitigation by GIP. Front Endocrinol (Lausanne). 2025;16:1530985. Published 2025 Feb 3. doi:10.3389/fendo.2025.1530985
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Frontiers in Endocrinology
Rights
Attribution 4.0 International Creative Commons licenses
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Permanent Link
https://hdl.handle.net/1805/46567
DOI
https://doi.org/10.3389/fendo.2025.1530985
Version
Final published version
Full Text Available at
This item is under embargo {{howLong}}
Collections
Open Access Policy Articles